Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Anaphylaxis (10)
  • Dermatology (11)
  • Mastocytosis and mast cells (1)
  • Microbiome (1)
  • Occupational allergy (2)
  • Ocular allergy (1)
  • Pediatrics (1)
Poster available until
  • Until platform closure (1)
Poster categories
  • Thematic Poster Session (25)
keywords
Session Reference
  • L-TPS01 (11)
  • L-TPS02 (15)
  • L-TPS03 (14)
  • L-TPS04 (12)
  • L-TPS05 (13)
  • L-TPS06 (8)
  • L-TPS07 (11)
  • L-TPS08 (7)
  • L-TPS09 (13)
  • L-TPS10 (13)
  • L-TPS11 (12)
  • L-TPS12 (14)
  • L-TPS13 (13)
  • L-TPS14 (11)
  • L-TPS15 (7)
  • L-TPS16 (14)
  • L-TPS17 (13)
  • L-TPS18 (10)
  • L-TPS19 (10)
  • L-TPS20 (12)
  • L-TPS21 (12)
  • TPS01 (12)
  • TPS02 (8)
  • TPS03 (14)
  • TPS04 (9)
  • TPS05 (15)
  • TPS06 (11)
  • TPS07 (13)
  • TPS08 (9)
  • TPS09 (9)
  • TPS10 (16)
  • TPS11 (13)
  • TPS12 (12)
  • x TPS13 (11)
  • TPS14 (12)
  • TPS15 (15)
  • TPS16 (15)
  • TPS17 (12)
  • TPS18 (10)
  • TPS19 (7)
  • TPS20 (11)
  • TPS21 (5)
  • x TPS22 (3)
  • TPS23 (4)
  • TPS25 (12)
  • TPS26 (14)
  • TPS27 (12)
  • TPS28 (16)
  • TPS29 (16)
  • TPS30 (14)
  • TPS31 (15)
  • TPS32 (16)
  • TPS33 (14)
  • TPS34 (17)
  • TPS35 (15)
  • TPS36 (12)
  • TPS37 (15)
  • TPS38 (13)
  • TPS39 (14)
  • TPS40 (13)
  • TPS41 (9)
  • TPS42 (12)
  • TPS43 (12)
  • TPS44 (14)
  • TPS45 (12)
  • TPS46 (8)
  • TPS47 (7)
  • TPS48 (5)
  • TPS49 (5)
  • TPS51 (12)
  • TPS52 (14)
  • TPS53 (8)
  • TPS54 (15)
  • TPS55 (13)
  • TPS56 (16)
  • TPS57 (12)
  • TPS58 (12)
  • TPS59 (13)
  • TPS60 (14)
  • TPS61 (11)
  • TPS62 (9)
  • TPS63 (10)
  • x TPS64 (11)
  • TPS65 (8)
  • TPS66 (9)
  • TPS67 (9)
  • TPS68 (19)
  • TPS69 (8)
  • TPS70 (9)
  • TPS71 (11)
  • TPS72 (6)
  • TPS73 (5)
  • TPS75 (4)
25 results
Thumbnail

D1.264 - Assessment by general practitioners of a therapeutic patient education guide for allergic patients

Thumbnail

D1.262 - Clinical significance of a basophil activation test for Japanese beekeepers naturally sensitized to honey bee venom

Thumbnail

D1.265 - Component-Resolved Diagnosis and Clinical Profiles of Anisakis Allergy in Japan

Thumbnail

D1.266 - Investigation of anaphylaxis in mastocytosis mouse models

Thumbnail

D1.267 - Recurrence of perioperative anaphylaxis: analysis of a multicenter cohort

Thumbnail

D1.268 - The endothelial glycocalyx as a therapeutic target in anaphylaxis

Thumbnail

D1.269 - Deciphering cardiovascular profiles in sera and extracellular vesicles from anaphylactic patients. Impact in endothelial cells

Thumbnail

D1.270 - Anaphylaxis and Adrenaline: Knowledge gaps with critical consequences

Thumbnail

D1.271 - Bovine gelatine-induced anaphylaxis brought on by eating beef, sweets containing gelatin, and medications

Thumbnail

D1.272 - Efficacy and Safety of Omalizumab in Treating Severe Allergic Reactions with Urticaria as the Initial Symptom

Thumbnail

D1.273 - Anaphylactic Reaction Following Sulphur Hexafluoride Administration

Thumbnail

D1.428 - Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation

Thumbnail

D1.431 - Associations of the composition of intestinal microbiota with the initial manifestations of IgE-mediated food allergy in children 6-12 months old

Thumbnail

D1.433 - The effect of preventive administration of probiotic strain E. coli 083:H24:K31 on selected immune characteristics of eight-year-old children

Thumbnail

D3.290 - Manifestations of allergic skin lesions in the early childhood and adult population: Epidemiological manifestations of diseases

Thumbnail

D3.291 - Hereditary angioedema with normal C1Inh and PLG mutation treated with tranexamic acid : Beware of the risk of thrombosis

Thumbnail

D3.292 - "Evaluating Inflammatory Markers in Chronic Spontaneous Urticaria: Impact of Omalizumab Treatment"

Thumbnail

D3.293 - Acrodermatitis chronica atrophicans in the field of scleroderma

Thumbnail

D3.295 - Mental health support for atopic dermatitis patients in the Republic of Kazakhstan

Thumbnail

D3.296 - Urticaria activity, quality of life and disease control in chronic spontaneous urticaria patients in Kazakhstan

Pagination

  • Current page 1
  • Page 2
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM